99% Purity Mazdutide in Stock cas 2259884-03-0 Grade: Pharmacy Grade
TDS 5 Inquiries
2259884-03-0
Pharmaceutical Grade
99%
ShangHai
DX
10mg/vial,10vials/box
Yes
2025-12-13
GLP-1,trizepatide,Semaglutide,Retatrutide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Mazdutide is a peptide-based GLP-1 and glucagon receptor (GCGR) dual agonist. As a pharmaceutical raw material, Mazdutide is characterized by its dual receptor activity and defined peptide structure. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Certificates-
TDS
Basic Info-
Product Name:
Mazdutide
Other Name:Mazdutide;Mazdutide acetate;Mazdutide 10mg;Mazdutide 5mg 10mg;LY-3305677;Mazdutide (IBI-362;OXM-3)
CAS No.:2259884-03-0
Molecular Weight:0
EC Number:884-103-0
Color/Form:White to off-white
Categories:
Research-
Class:
Dual GLP-1R/GCGR agonist (long-acting peptide)
Status:Investigational — Phase 3 (China)
Mechanism:A long-acting dual agonist of the GLP-1 receptor (GLP-1R, Ki = 28.6 nM) and glucagon receptor (GCGR, Ki = 17.7 nM). The dual activation provides both glycemic control (via GLP-1R) and increased energy expenditure / hepatic lipolysis (via GCGR), producing weight loss beyond what GLP-1R agonism alone achieves.
EC50 (GLP1R Ki):28.6 nM
EC50 (GCGR Ki):17.7 nM
Source:GlpBio: Mazdutide (CAS 2259884-03-0); Innovent Phase Ib results (eClinicalMedicine 2022).DOI
Clinical Development:
References-
PubChem:Literature:
GlpBio: Mazdutide (CAS 2259884-03-0); eClinicalMedicine: Innovent Phase Ib results (2022); ClinicalTrials.gov: DREAMS-1 (NCT04930343)
Disclaimer:Mazdutide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials in China. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,trizepatide,Semaglutide,Retatrutide
-
Location:
Room 2012, No. 6-143, Section 2, Shanghai Road, Guta District, Jinzhou City, Liaoning Province
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
2 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2024
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted
United States
Mazdutide
25 MG Aug 12, 2026
Nigeria
Mazdutide 10mg
20 PCS Mar 7, 2026
United Kingdom
Mazdutide
1 KG Feb 10, 2026
United States
Mazddultide cas
2 MT Nov 14, 2025
United States
Mazdutide
30 MG Jul 15, 2024 Post an enquiry for this product
More from this Seller
-
-
-
Elamipretide SS-31 Peptide Powder CAS 736992-21-5 Cosmetic Raw Material
Pharmaceutical Grade / 99%
-
-
-
-
High purity over 99% igf-des raw powder fast shipping factory derect supply wholesale cas no 112603-35-7
Pharmaceutical Grade / 99%
-
-
-
-
Survodutide high purity factory derect supply cas no 2805997-46-8 raw material fast shipping
Pharmaceutical Grade / 99%
-
-
-
-
Hot selling high purity synergistic weight management peptide cagrilintide
Pharmaceutical Grade / 99%
-
-
-
-
Over 99% Purity Pharmaceutical Grade 5-amino-1mq white powder cas 42464-96-0 Raw material powder
Pharmaceutical Grade / 99.9%
-
-
-
-
Factory derectly supply high purity selank raw powder cas no: 129954-34-3
Pharmaceutical Grade / 99.9%
-
